Octagon Capital Advisors »

Eyepoint Pharmaceuticals shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.7M 1.1M 7.99
2024-06-30 $9.5M 1.1M 8.70
2024-03-31 $23M 1.1M 20.67

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals (APLS)
Verona Pharma Sponsored Ads (VRNA)
Structure Therapeutics Sponsored Ads (GPCR)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Arrivent Biopharma (AVBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Nuvation Bio Com Cl A (NUVB)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Ocular Therapeutix (OCUL)
Miragen Therapeutics (VRDN)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Cogent Biosciences (COGT)
Bridgebio Pharma (BBIO)

View all positions for Octagon Capital Advisors

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
BlackRock
Franklin Resources
BlackRock
Vanguard Group
T. Rowe Price Associates
Morgan Stanley
Federated Investors
Citadel Advisors
Patient Square Capital
T. Rowe Price Investment Management
State Street Corporation
Geode Capital Management
Octagon Capital Advisors

View all funds holding Eyepoint Pharmaceuticals